Anaferon baby drops for oral administration fl.-cap. 25ml # 1

In the course of preclinical and clinical studies, the effectiveness of the drug against influenza viruses, herpes simplex viruses types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), rotavirus has been proven. The drug reduces the concentration of the virus in the affected tissues , influences the system of endogenous interferons and associated cytokines, induces the formation of endogenous early" interferons (IFN a /?) and interferon gamma (IFN?). Stimulates the humoral and cellular immune response. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), and normalizes their ratio. Increases the functional reserve of Th and other cells involved in the immune response. It is an inducer of mixed Txl and Tx2 immune responses:increases the production of cytokines Txl (IFN?, IL-2) and Тх2 (IL-4, 10), restores (modulates) the balance Тх1 / Тх2. Increases the functional activity of phagocytes and natural killer cells (EK cells).

Name ENG

ANAFERON KID

Clinical and pharmacological group

Antiviral drug.

Immunomodulator

ATX code

Other antiviral drugs, Immunostimulants

Dosage

0.006g / ml x 25ml

Structure

Composition for 1 ml drops for oral administration.

Active substances: Affinity purified antibodies to human gamma interferon - 0.006 g *.

* are introduced as a mixture of three active aqueous dilutions of the substance, diluted 100 ^ 12, 100 ^ 30, 100 ^ 50 times, respectively.

Excipients: maltitol - 0.06 g, glycerol - 0.03 g, potassium sorbate - 0.00165 g, anhydrous citric acid - 0.0002 g, purified water - up to 1 ml.

Indications

Prevention and treatment of influenza, acute respiratory viral infections, viral infections of the upper respiratory tract (initis, pharyngitis, laryngitis, tracheobronchitis). Complex therapy and prevention of chronic recurrent herpesvirus infection, including simple genital herpes. Treatment of secondary complications of immunodeficiency states of various etiologies and. viral and bacterial infections.

INN / Active ingredient

Homeopathic composition

Contraindications

Individual hypersensitivity to the components of the drug, children up to 1 month of age, Hereditary fructose intolerance (due to the presence of maltitol in the composition).

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the drug

The immune system

Release form

Drops

Manufacturer country

Russia

Package quantity, pcs

one

Minimum age from

1 month

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

25 ml

Brand name

Materia Medica Holding

Components

dropper

The amount of the dosage form in the primary package

25 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiviral and immunostimulating agent

Anatomical and therapeutic characteristics

J05AX Other antiviral drugs

Dosage form

Drops for oral administration

Expiration date in days

1095

The target audience

Children

Package weight, g

fifty

Mode of application

:

10 drops per dose (the drops are dosed into a spoon).

On the first day of treatment: the first 2 hours, 10 drops every 30 minutes, then, in the remaining time, 3 more times at regular intervals.

From the 2nd to the 5th day: 10 drops, 3 times a day.

The drug is taken outside of meals.

On the first day of treatment, the first five doses of the drug should be carried out between feedings or 15 minutes before feeding the baby or taking fluids.

Dosage (volume) of the substance in the preparation

:

antibodies to human gamma interferon affinity purified 0.006 g

"